Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 54; no. 6; pp. 903 - 906
Main Authors Kim, Hee-Je, Sohn, Hyun-Jung, Hong, Jung-A, Lee, Hyun-Joo, Sohn, Dae-Hee, Shin, Chang-Ae, Cho, Hyun-Il, Min, Woo-Sung, Kim, Tai-Gyu
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2019
Nature Publishing Group
Subjects
631/250/2152/1566/1618
631/250/251
96/21
96/31
Acute myeloid leukemia
Adult
Cell Biology
Correspondence
Female
Hematology
Humans
Immunotherapy
Immunotherapy - methods
Internal Medicine
Leukemia
Leukemia, Myeloid, Acute - drug therapy
Male
Medicine
Medicine & Public Health
Middle Aged
Myeloid leukemia
Polymerase chain reaction
Prospective Studies
Public Health
Stem Cells
T-Lymphocytes, Cytotoxic - metabolism
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Feature-1
ObjectType-Correspondence-3
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-018-0383-2